Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Net Cash Flow (2020 - 2025)

Intelligent Bio Solutions has reported Net Cash Flow over the past 5 years, most recently at $8.3 million for Q1 2024.

  • For Q1 2024, Net Cash Flow rose 1427.71% year-over-year to $8.3 million; the TTM value through Jun 2024 reached $4.1 million, up 165.7%, while the annual FY2023 figure was -$6.6 million, 56.58% down from the prior year.
  • Net Cash Flow for Q1 2024 was $8.3 million at Intelligent Bio Solutions, up from -$2.9 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $18.8 million in Q4 2020 and troughed at -$5.7 million in Q1 2021.
  • A 5-year average of $356442.6 and a median of -$719978.0 in 2023 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: plummeted 2955.07% in 2022 and later soared 1427.71% in 2024.
  • Year by year, Net Cash Flow stood at $18.8 million in 2020, then crashed by 107.57% to -$1.4 million in 2021, then crashed by 81.83% to -$2.6 million in 2022, then decreased by 10.69% to -$2.9 million in 2023, then skyrocketed by 390.16% to $8.3 million in 2024.
  • Business Quant data shows Net Cash Flow for INBS at $8.3 million in Q1 2024, -$2.9 million in Q4 2023, and -$1.3 million in Q3 2023.